PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes |
| September 07, 2011 | September 2011 Bond Updates |
|
INCLINE VILLAGE, Nev., Sept. 7, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced adjustments to the conversion rates for:
The 2.875% Convertible Senior Notes due February 15, 2015 (the February 2015 Notes), effective September 9, 2011; andThe 3.75% Convertible... |
| View more at: http://www.prnewswire.com/news-releases/pdl-biopharma-announces-conversion-rate-adjustments-for-its-convertible-notes-129363238.html |
| Related News |
|